Breast Cancer Research

official impact factor 5.79

Download references

Open Access Highly Access

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

Sacha J Howell*, Elizabeth Anderson, Tom Hunter, Gillian Farnie and Robert B Clarke

Breast Cancer Research 2008, 10:R68 doi:10.1186/bcr2129

Include


Format